Cargando…

Aggressive tumors and difficult choices in acromegaly

PURPOSE: The current article looks at some of the factors associated with pituitary adenomas displaying unusually aggressive biological and clinical behaviour in patients with acromegaly. METHODS: This was a retrospective, narrative review of previously published evidence chosen at the authors’ disc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrasco, Carmen A., Gadelha, Mônica, Manavela, Marcos, Bruno, Oscar D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906541/ https://www.ncbi.nlm.nih.gov/pubmed/24293348 http://dx.doi.org/10.1007/s11102-013-0538-5

Ejemplares similares

Implementing a screening program for acromegaly in Latin America: necessity versus feasibility
por: Danilowicz, Karina, et al.
Publicado: (2016)

The role of primary pharmacological therapy in acromegaly
por: de los Monteros, Ana Laura Espinosa, et al.
Publicado: (2013)

Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina
por: Bruno, Oscar D., et al.
Publicado: (2015)

The genetic background of acromegaly
por: Gadelha, Mônica R., et al.
Publicado: (2017)

Novel therapies for acromegaly
por: Maia, Bernardo, et al.
Publicado: (2020)

Acromegaly and Colorectal Neoplasm: An Update
por: Kasuki, Leandro, et al.
Publicado: (2022)

The Future of Somatostatin Receptor Ligands in Acromegaly
por: Gadelha, Monica R, et al.
Publicado: (2021)

Determinants of morbidities and mortality in acromegaly
por: Kasuki, Leandro, et al.
Publicado: (2019)

Management of acromegaly in Latin America: expert panel recommendations
por: Barkan, Ariel, et al.
Publicado: (2009)

Pegvisomant in acromegaly: a multicenter real-life study in Argentina
por: Basavilbaso, Natalia Ximena Garcia, et al.
Publicado: (2019)

High levels of IGF-1 predict difficult intubation of patients with acromegaly
por: Zhang, Yu, et al.
Publicado: (2017)

Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
por: Colao, Annamaria, et al.
Publicado: (2015)

Long-term, real-world experience of pasireotide dose reduction in patients with acromegaly
por: Marques, Nelma Veronica, et al.
Publicado: (2023)

Pulmonary function testing and chest tomography in patients with acromegaly
por: Camilo, Gustavo Bittencourt, et al.
Publicado: (2013)

Pain or constipation: A difficult choice
por: Anjan, Trikha, et al.
Publicado: (2012)

Risk factors and management of pasireotide-associated hyperglycemia in acromegaly
por: Gadelha, Mônica R, et al.
Publicado: (2020)

MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands
por: Henriques, Daniel G., et al.
Publicado: (2022)

A Pituitary Society update to acromegaly management guidelines
por: Fleseriu, Maria, et al.
Publicado: (2020)

Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors
por: Bianchi, Antonio, et al.
Publicado: (2023)

A practical approach to acromegaly management in Latin America
por: Bronstein, Marcello D., et al.
Publicado: (2013)

THU483 Role Of Excess GH On Breast Cancer Aggressiveness And Metastasis In Acromegaly
por: Hun, Ju, et al.
Publicado: (2023)

Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly
por: Schmid, Herbert A., et al.
Publicado: (2016)

Brazilian multicenter study on pegvisomant treatment in acromegaly
por: Boguszewski, Cesar L., et al.
Publicado: (2019)

SAT-455 Analysis of a Group of Prolactinomas Resistant to Treatment with Dopamine Agonists at a University Hospital in Buenos Aires, Argentina
por: Gonzalez Pernas, Mariana, et al.
Publicado: (2019)

A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression
por: Leporati, Paola, et al.
Publicado: (2015)

Acromegaly
por: Gibson, G. A.
Publicado: (1899)

Preference of acromegaly patients for treatment attributes in Spain
por: Fajardo, Carmen, et al.
Publicado: (2023)

Africa faces difficult choices in responding to COVID-19
por: Divala, Titus, et al.
Publicado: (2020)

Subclinical Ventricular Dysfunction in Long-Term Acromegaly Assessed by Speckle-Tracking Echocardiography
por: Gadelha, Patricia, et al.
Publicado: (2022)

On the Functional Capacity and Quality of Life of Patients with Acromegaly: Are They Candidates for Rehabilitation Programs?
por: Guedes da Silva, Débora Pedroza, et al.
Publicado: (2013)

Clinical and functional variables can predict general fatigue in patients with acromegaly: an explanatory model approach
por: Michalski, André da Cunha, et al.
Publicado: (2019)

Acromegaly
por: Chanson, Philippe, et al.
Publicado: (2008)

Acromegaly
Publicado: (1932)

Acromegaly
Publicado: (1890)

A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly
por: Fleseriu, M., et al.
Publicado: (2022)

Challenges in the diagnosis and management of acromegaly: a focus on comorbidities
por: Abreu, Alin, et al.
Publicado: (2016)

Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study
por: Colao, Annamaria, et al.
Publicado: (2020)

Radiographic findings in acromegaly: pictorial essay
por: Baptista, Luisa Couto, et al.
Publicado: (2023)

Molecular evidence and clinical importance of β‐arrestins expression in patients with acromegaly
por: Coelho, Maria Caroline Alves, et al.
Publicado: (2018)

Pregnancy and acromegaly
por: Muhammad, Ammar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9tvpncua5grvi7v1svarp4o20d